Nonmotor symptoms of Parkinson’s disease.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Nonmotor Symptoms of Parkinson’s Disease.”. Expert Rev Neurother.
Search
Search results
134 results found
Identification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005;20: 726-733.
Stacy, M, A Bowron, M Guttman, R Hauser, K Hughes, JP Larsen, P LeWitt, et al. 2005. “Identification of Motor and Nonmotor Wearing-off in Parkinson’s Disease: Comparison of a Patient Questionnaire versus a Clinician Assessment. Mov Disord 2005;20: 726-733.”. Mov Disord.
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson’s disease.
Sullivan, KL, JK Staffetti, RA Hauser, PB Dunne, and TA Zesiewicz. 2006. “Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease.”. Movement Disorders.
Clinical trials aimed at detecting neuroprotection in Parkinson’s disease.
Hauser, RA, and T Zesiewicz. 2006. “Clinical Trials Aimed at Detecting Neuroprotection in Parkinson’s Disease.”. Neurology.
Use of nutritional supplements in Parkinson’s disease patients.
Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch Neurol 2006;63:1181-1184.
Graff-Radford, J, KD Foote, RL Rodriguez, HH Fernandez, RA Hauser, and . 2006. “Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia. Arch Neurol 2006;63:1181-1184.”. Arch Neurol.
Levodopa/carbidopa/entacapone for the treatment of Parkinson’s disease.
Samanta, J, and RA Hauser. 2006. “Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease.”. Aging Health.
Ropinirole therapy for Parkinson’s disease. Expert Review of Neurotherapeutics 2004;4:581-588.
Pahwa, R, K Lyons, and RA Hauser. 2004. “Ropinirole Therapy for Parkinson’s Disease. Expert Review of Neurotherapeutics 2004;4:581-588.”. Expert Review of Neurotherapeutics.
Future treatments for Parkinson’s disease. Neurol Clin 2004;22(Suppl 3):S149-166.
Hauser, RA, and K Lyons. 2004. “Future Treatments for Parkinson’s Disease. Neurol Clin 2004;22(Suppl 3):S149-166.”. Neurol Clin.
Management of essential tremor. Curr Neurol Neurosci Rep 2002;2:324-330.
Zesiewicz, TA, E Encarnacion, and RA Hauser. 2002. “Management of Essential Tremor. Curr Neurol Neurosci Rep 2002;2:324-330.”. Curr Neurol Neurosci Rep.